Fredun Pharmaceuticals Limited (BOM:539730)
India · Delayed Price · Currency is INR 1,474.10
-14.10 (-0.95%)
At close: Sep 4, 2026
Fredun Pharmaceuticals Market Cap
Fredun Pharmaceuticals has a market cap or net worth of 24.38 billion as of September 4, 2026. Its market cap has increased by 315.00% in one year.
Market Cap
24.38B
Enterprise Value
26.15B
Revenue
7.44B
Ranking
n/a
PE Ratio
62.79
Stock Price
1,474.10
ChartMarket Cap Chart
Since March 28, 2016, Fredun Pharmaceuticals's market cap has increased from 29.40M to 24.38B, an increase of 82,806.90%. That is a compound annual growth rate of 90.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 24.38B | 227.14% |
| Dec 31, 2025 | 7.45B | 115.10% |
| Dec 31, 2024 | 3.46B | -15.14% |
| Dec 29, 2023 | 4.08B | -20.69% |
| Dec 30, 2022 | 5.15B | 37.31% |
| Dec 31, 2021 | 3.75B | 116.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 26, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Gufic Biosciences | 44.67B |
| Novartis India | 40.42B |
| Unichem Laboratories | 38.79B |
| Kwality Pharmaceuticals | 34.18B |
| Hikal | 27.40B |
| Shukra Pharmaceuticals | 22.84B |
| Venus Remedies | 22.58B |
| Syncom Formulations (India) | 19.33B |